Skip to main content
Top

Cellular Oncology

Issue 4/2016

Content (8 Articles)

Original Paper

Prognostic implications of securin expression and sub-cellular localization in human breast cancer

N. Gurvits, H. Repo, E. Löyttyniemi, M. Nykänen, J. Anttinen, T. Kuopio, K. Talvinen, P. Kronqvist

Original Paper

Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway

Junshan Liu, Xiduan Wei, Yafeng Wu, Yanni Wang, Yuwen Qiu, Junmin Shi, Hongling Zhou, Zibin Lu, Meng Shao, Linzhong Yu, Li Tong

Original Paper

Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations

Yong-Xia Bao, Xiao-Dan Zhao, Hong-Bin Deng, Chang-Lian Lu, Yang Guo, Xing Lu, Li-Li Deng

Open Access Original Paper

TNF-α promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid rafts

Dominika Wolczyk, Magdalena Zaremba-Czogalla, Anita Hryniewicz-Jankowska, Renata Tabola, Krzysztof Grabowski, Aleksander F. Sikorski, Katarzyna Augoff

Original Paper

High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells

Luis Antonio Flores-López, María Guadalupe Martínez-Hernández, Rubí Viedma-Rodríguez, Margarita Díaz-Flores, Luis Arturo Baiza-Gutman

Original Paper

Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development

Matteo Giulietti, Giulia Occhipinti, Giovanni Principato, Francesco Piva

Report

Inactivation of the LKB1-AMPK signaling pathway does not contribute to salivary gland tumor development - a short report

Natascha Cidlinsky, Giada Dogliotti, Tobias Pukrop, Rudolf Jung, Florian Weber, Michael P. Krahn

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine